Vol 2: Glycomic Expression in Esophageal Disease.Report as inadecuate



 Vol 2: Glycomic Expression in Esophageal Disease.


Vol 2: Glycomic Expression in Esophageal Disease. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 2: Glycomic Expression in Esophageal Disease.
This article is from Metabolites, volume 2.AbstractGlycosylation is among the most common post translation modifications of proteins in humans. Decades of research have demonstrated that aberrant glycosylation can lead to malignant degeneration. Glycoproteomic studies in the past several years have identified techniques that can successfully characterize a glycan or glycan profile associated with a high-grade dysplastic or malignant state. This review summarizes the current glycomic and glycoproteomic literature with specific reference to esophageal cancer. Esophageal adenocarcinoma represents a highly morbid and mortal cancer with a defined progression from metaplasia (Barretts esophagus) to dysplasia to neoplasia. This disease is highlighted because (1) differences in glycan profiles between the stages of disease progression have been described in the glycoproteomic literature; (2) a glycan biomarker that identifies a given stage may be used as a predictor of disease progression and thus may have significant influence over clinical management; and (3) the differences in glycan profiles between disease and disease-free states in esophageal cancer are more dramatic than in other cancers.



Author: Mohanty, Sanjay; Tsiouris, Athanasios; Hammoud, Zane

Source: https://archive.org/



DOWNLOAD PDF




Related documents